Dosidal · Switzerland

Nexviadyme, poudre pour solution à diluer pour perfusion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67871 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67871
atc: A16AB22
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-11-17
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A16AB22
authorisation_number: 67871
form: PULPI
holder: Sanofi-Aventis (Suisse) SA
holder_partner_nr: 1005874
it_number: 07.14.0.
name: Nexviadyme, poudre pour solution à diluer pour perfusion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
6Nl0IMoMdM88R_89V-JnOqAqGwmVq5hvznS55KlawddNGOW0CQ5qhTl-6r7_9RZqG8IhkPjbzYcD1tIRY93OJw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal